Sort
10,829 grants matching “car t”
SPORE in Lymphoma
$2,133,312Helen E Heslop · Baylor College Of Medicine · P50 · FY2021 · CA
Molecular Pathways for Hypertrophy and Cardiomyopathy
$2,131,521Kirk U Knowlton · University Of California, San Diego · P01 · FY2008 · HL
Training At-Risk Industrial, Telecommunication and Immigrant Workers on How to Protect Themselves from Exposure to Hazardous Materials and Hazardous Waste Products
$2,129,478James S Frederick · Steelworker Charitable/Educational Org · U45 · FY2016 · ES
Columbia/Cornell/Harlem Hospital Precision Medicine Initiative HPO
$2,128,967David B. Goldstein · Columbia University Health Sciences · UG3 · FY2017 · OD
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
$2,125,666Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system
$2,125,666Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Specialized Program of Research Excellence (SPORE) in Leukemia
$2,109,864Daniel C Link · Washington University · P50 · FY2024 · CA
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,105,511Steven Mark Albelda · University Of Pennsylvania · P01 · FY2018 · CA
NORTHERN CALIFORNIA COMPREHENSIVE SICKLE CELL CENTERS
$2,103,081Children'S Hospital &Res Ctr At Oakland · U54 · FY2004 · HL
NORTHERN CALIFORNIA COMPREHENSIVE SICKLE CELL CENTERS
$2,102,693Children'S Hospital &Res Ctr At Oakland · U54 · FY2005 · HL
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
$2,101,526John E Wagner · University Of Minnesota · P01 · FY2023 · CA
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,101,502Steven Mark Albelda · University Of Pennsylvania · P01 · FY2020 · CA
Extending Chimeric Antigen (CAR) T cell therapy to thoracic cancers
$2,101,502Steven Mark Albelda · University Of Pennsylvania · P01 · FY2021 · CA
Mobile health strategies to support longitudinal engagement in harm reduction services
$2,100,905Ryan Patrick Westergaard · University Of Wisconsin-Madison · R01 · FY2022 · DA
Center for Research and Education on Aging and Technology Enhancement - CREATE IV
$2,098,920Sara J. Czaja · University Of Miami School Of Medicine · P01 · FY2016 · AG
NGTC - UCL
$2,095,142Martin Pule · University College London · OT2 · FY2022 · CA
Mayo Clinic Ovarian Cancer SPORE
$2,093,975Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2025 · CA
MSK SPORE in Lymphoma
$2,093,966Andrew D. Zelenetz · Sloan-Kettering Inst Can Research · P50 · FY2019 · CA
Expansion of antigen-specific T cells using programmable biomaterials for adoptive cellular therapy
$2,090,715Catherine Ju-Ying Wu · Harvard University · U54 · FY2019 · CA
SPORE in Brain Cancer
$2,088,365Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2024 · CA
CAR-T Therapy of Mesothelin Expressing Cancers
$2,085,050Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Off-the-Shelf Immune Effector Cells for Hematological Malignancies
$2,080,518John E Wagner · University Of Minnesota · P01 · FY2025 · CA
IGF::OT::IGF FISHER BIOSERVICES, INC.; HHSN261201600006I;DTP-16-027; DTP R&D CAN# 8422741; TITLE: REGISTRATION, STORAGEAND DISTRIBUTION OF CHEMICALS AND DRUGS FOR PRE-CLINICAL DISCOVERY,EVALUATION AND
$2,078,564Doug Smallwood · Fisher Bioservices, Inc. · N02 · FY2016 · CA
SPORE in Lymphoma
$2,075,728Helen E Heslop · Baylor College Of Medicine · P50 · FY2024 · CA
Collaborative Research: Molecular Programming Architectures, Abstractions, Algorithms, and Applications
$2,075,000Eric Klavins · University Of Washington · · FY2013 · CSE